Vanguard Group’s Generation Bio GBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $735K | Sell |
229,835
-32,136
| -12% | -$103K | ﹤0.01% | 3832 |
|
|
2025
Q1 | $1.06M | Sell |
261,971
-2,229
| -0.8% | -$9.03K | ﹤0.01% | 3691 |
|
|
2024
Q4 | $2.8M | Buy |
264,200
+628
| +0.2% | +$6.66K | ﹤0.01% | 3462 |
|
|
2024
Q3 | $6.51M | Buy |
263,572
+4,715
| +2% | +$116K | ﹤0.01% | 3159 |
|
|
2024
Q2 | $7.3M | Buy |
258,857
+1,811
| +0.7% | +$51.1K | ﹤0.01% | 3078 |
|
|
2024
Q1 | $10.5M | Buy |
257,046
+1,821
| +0.7% | +$74.1K | ﹤0.01% | 2942 |
|
|
2023
Q4 | $4.21M | Buy |
255,225
+21,347
| +9% | +$352K | ﹤0.01% | 3350 |
|
|
2023
Q3 | $8.86M | Buy |
233,878
+7,952
| +4% | +$301K | ﹤0.01% | 2949 |
|
|
2023
Q2 | $12.4M | Buy |
225,926
+1,661
| +0.7% | +$91.4K | ﹤0.01% | 2822 |
|
|
2023
Q1 | $9.64M | Buy |
224,265
+1,115
| +0.5% | +$47.9K | ﹤0.01% | 2953 |
|
|
2022
Q4 | $8.77M | Buy |
223,150
+1,298
| +0.6% | +$51K | ﹤0.01% | 3013 |
|
|
2022
Q3 | $11.8M | Buy |
221,852
+821
| +0.4% | +$43.6K | ﹤0.01% | 2873 |
|
|
2022
Q2 | $14.5M | Sell |
221,031
-133,887
| -38% | -$8.78M | ﹤0.01% | 2796 |
|
|
2022
Q1 | $26.1M | Sell |
354,918
-4,528
| -1% | -$332K | ﹤0.01% | 2632 |
|
|
2021
Q4 | $25.4M | Buy |
359,446
+4,338
| +1% | +$307K | ﹤0.01% | 2713 |
|
|
2021
Q3 | $89M | Buy |
355,108
+32,575
| +10% | +$8.17M | ﹤0.01% | 2039 |
|
|
2021
Q2 | $86.8M | Buy |
322,533
+28,995
| +10% | +$7.8M | ﹤0.01% | 2065 |
|
|
2021
Q1 | $83.5M | Buy |
293,538
+200,893
| +217% | +$57.2M | ﹤0.01% | 2048 |
|
|
2020
Q4 | $26.3M | Buy |
92,645
+7,840
| +9% | +$2.22M | ﹤0.01% | 2503 |
|
|
2020
Q3 | $26.2M | Buy |
84,805
+79,805
| +1,596% | +$24.7M | ﹤0.01% | 2325 |
|
|
2020
Q2 | $1.05M | Buy |
+5,000
| New | +$1.05M | ﹤0.01% | 3605 |
|